Literature DB >> 22315175

Sleep quality and daytime sleepiness in patients with epilepsy.

Nai-Ching Chen1, Meng-Han Tsai, Chiung-Chih Chang, Cheng-Hsien Lu, Wen-Neng Chang, Shung-Lon Lai, Yu-Lung Tseng, Yao-Chung Chuang.   

Abstract

PURPOSE: Poor sleep quality and excessive daytime sleepiness (EDS) are common complaints of patients with epilepsy (PWE). This study aimed to evaluate possible predisposing factors for EDS and subjective sleep quality in PWE.
METHODS: One hundred and seventeen PWE were enrolled and 30 healthy volunteers were recruited as controls. EDS was evaluated by the Epworth Sleepiness Scale (ESS) while the Pittsburg Sleep Quality Index (PSQI) was designed to evaluate overall sleep quality. Clinical baseline data and possible risk factors for sleep disturbances were included in the statistical analysis.
RESULTS: Twenty percent of PWE (23/117) and 7% of healthy controls (2/30) had excessive daytime sleepiness (p = 0.007). PWE had significantly higher PSQI total scores (6.5 ± 3.8 vs. 3.7 ± 2.9), sleep latency (1.2 ± 0.8 vs. 0.6 ± 0.7) and sleep efficiency (0.8 ± 1.0 vs. 0.0 ± 0.2) scores than the controls (all p < 0.001). A significantly higher prevalence of poor sleep quality was found in the partial seizure, non-seizure-free, and polytherapy groups (all p < 0.05). Multivariate analysis showed that poor seizure control was the strongest independent risk factor for poor sleep quality (OR = 2.43, 95% CI = 1.15-5.15, p = 0.02).
CONCLUSION: EDS and poor sleep quality are common in PWE and are closely related to partial epilepsy, poor seizure control, and polytherapy. These relationships must be addressed in order to provide the best management of sleep disturbance in such patients.

Entities:  

Mesh:

Year:  2011        PMID: 22315175

Source DB:  PubMed          Journal:  Acta Neurol Taiwan        ISSN: 1028-768X


  9 in total

1.  Sleep Quality and Associated Factors among Peoples with Epilepsy Who Have a Follow-Up at Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia, 2019: An Institutional Based Cross-Sectional Study.

Authors:  Kemeriya Adem; Tilahun Kassew; Addis Birhanu; Ayalew Abate
Journal:  Psychiatry J       Date:  2020-07-26

2.  Perceived Changes in Sleep in Adults With Epilepsy.

Authors:  Wendy R Miller; Julie L Otte; Madona Pleuger
Journal:  J Neurosci Nurs       Date:  2016 Jul-Aug       Impact factor: 1.230

Review 3.  Impaired vigilance networks in temporal lobe epilepsy: Mechanisms and clinical implications.

Authors:  Dario J Englot; Victoria L Morgan; Catie Chang
Journal:  Epilepsia       Date:  2020-01-04       Impact factor: 5.864

Review 4.  Excessive daytime sleepiness and epilepsy: a systematic review.

Authors:  Andre S Giorelli; Pâmela Passos; Thiago Carnaval; Marleide da Mota Gomes
Journal:  Epilepsy Res Treat       Date:  2013-10-31

5.  Sleep disturbances among patients with epilepsy.

Authors:  Anna Staniszewska; Agnieszka Mąka; Urszula Religioni; Dominik Olejniczak
Journal:  Neuropsychiatr Dis Treat       Date:  2017-07-10       Impact factor: 2.570

6.  Efficacy of Phenobarbital and Prognosis Predictors in Women With Epilepsy From Rural Northeast China: A 10-Year Follow-Up Study.

Authors:  Chaojia Chu; Nan Li; Rui Zhong; Danyang Zhao; Weihong Lin
Journal:  Front Neurol       Date:  2022-02-16       Impact factor: 4.003

Review 7.  Sleep Disruption Worsens Seizures: Neuroinflammation as a Potential Mechanistic Link.

Authors:  Herlinda Bonilla-Jaime; Helena Zeleke; Asheebo Rojas; Claudia Espinosa-Garcia
Journal:  Int J Mol Sci       Date:  2021-11-20       Impact factor: 5.923

8.  Sleep quality and associated factors among adult patients with epilepsy attending follow-up care at referral hospitals in Amhara region, Ethiopia.

Authors:  Sintayehu Simie Tsega; Birhaneselassie Gebeyehu Yazew; Kennean Mekonnen
Journal:  PLoS One       Date:  2021-12-10       Impact factor: 3.240

9.  Sleep and Temporal Lobe Epilepsy - Associations, Mechanisms and Treatment Implications.

Authors:  Divyani Garg; Laurel Charlesworth; Garima Shukla
Journal:  Front Hum Neurosci       Date:  2022-04-26       Impact factor: 3.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.